Articles written by Globe Newswire - Benzinga

BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioVie Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against BioVie Inc. (NASDAQ:BIVI) on behalf of

LANDSTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating Landstar System, Inc. on Behalf of Landstar Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Landstar System, Inc. ("Landstar" or the

FEC Sponsors "Dubai Token 2049 Meta Crypto Oasis" Event — A Resounding Success

Dubai, UAE, April 30, 2025 (GLOBE NEWSWIRE) -- On April 29, 2025, the highly anticipated "Dubai Token 2049 Meta Crypto Oasis" event was successfully held in Dubai. FEC (Fortune Earning Coupon), the event's premier

BACKBLAZE ALERT: Bragar Eagel & Squire, P.C. is Investigating Backblaze, Inc. on Behalf of Backblaze Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Backblaze, Inc. ("Backblaze" or the

GDR Labs PhytoTest+ Under Review: Legal OTC Sublingual Testosterone with No Prescription Needed

New York, April 30, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: The real reasons behind declining testosterone levels in men over 30Why traditional testosterone replacement therapy (TRT) may not be

Kelso Technologies Inc. Financial Results for the Three Months Ended March 31, 2025

WEST KELOWNA, British Columbia and BONHAM, Texas, April 30, 2025 (GLOBE NEWSWIRE) -- Kelso Technologies Inc. ("Kelso" or the "Company"),(TSX:KLS) reports that the Company has released the unaudited interim consolidated

ETH is about to skyrocket? SIX MINING helps you earn passive income every day

london, united kingdom, April 30, 2025 (GLOBE NEWSWIRE) -- london, united kingdom Apr 30, 2025 (Copper) BlackRock, the world's largest asset management company, purchased $67.5 million worth of Ethereum (ETH)

Prospera Energy Announces 2024 Financial Results

CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- Prospera Energy Inc. ((TSX.V: PEI, OTC:GXRFF) ("Prospera", "PEI" or the "Corporation") In Q4 2024, Prospera Energy underwent a strategic transformation under new

ANTI TAR Cigarette Filters Under Review: TripleGuard Filtration Tips for Cleaner Smoking Experience

New York, April 30, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: The smoking-related discomforts and pain points that most filters fail to solveWhy ANTI TAR TripleGuard filters stand out as a

Aimfinity Investment Corp. I Announces Transition from Nasdaq to OTC Markets and New Monthly Extension for Business Combination

Wilmington, DE, April 30, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the "AIMA") (NASDAQ:AIMAU), a special purpose acquisition company, today announced that, as anticipated, AIMA received a notice from The

Magnesium Breakthrough Under Review: Best Magnesium Supplement with Premium Ingredients Complex by BiOptimizers

New York, April 30, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: Why modern magnesium deficiency affects more than 50% of adults todayThe overlooked symptoms and health issues linked to low magnesium

Christina Lake Cannabis Closes First Tranche of Non-Brokered Private Placement

VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (the "Company" or "CLC" or "Christina Lake Cannabis") (CSE:CLC) (OTCQB:CLCFF) (FRANKFURT: CLB) further to the press release

Ultimate Medical Academy Hosts Student Training Event with Major Vehicle Trauma Simulation and TGH Helicopter Rescue

Tampa, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Ultimate Medical Academy (UMA), a non-profit higher education institution with the mission of equipping and empowering students to excel in healthcare careers, hosted a

Best Legal Steroids Under Review: The Best Legal Product Brand for Sale on the Market (Crazy Bulk)

New York, April 30, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: What legal steroids are, and how do they compare to traditional anabolic steroidsThe real challenges fitness enthusiasts face when

Breathing for Sleep Under Review: Healthy Tongue Posture Trick Routine for Deeper Sleep by Zach Zenios

New York, April 30, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: Why disrupted tongue posture and poor breathing habits may be the hidden reason behind your sleepless nightsHow the Breathing for Sleep

Nxera Pharma's Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia

NBI-1117568 is an oral, muscarinic M4 selective receptor agonist discovered by Nxera advancing through clinical development under a multi-program collaboration with NeurocrineFor more information, please read

Sacred Journey Recovery Launches Adventure Addiction Treatment Program in California, Redefining Recovery Through Nature and Brotherhood

Vista, April 30, 2025 (GLOBE NEWSWIRE) -- Vista, California – April 23, 2025 – Sacred Journey Recovery proudly announces the launch of its Adventure Addiction Treatment program. This innovative initiative integrates

Postal Realty Trust, Inc. Reports First Quarter 2025 Results

- Agreed to New Rents on all 2025 & 2026 Negotiated Leases -- Acquired 36 USPS Properties for $15.8 million at a Weighted Average Capitalization Rate of 7.6% - CEDARHURST, N.Y., April 30, 2025 (GLOBE NEWSWIRE) --

Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States

Amicus licenses exclusive U.S. rights to commercialize DMX-200 for the treatmentof Focal Segmental Glomerulosclerosis (FSGS) DMX-200 is in a pivotal Phase 3 trial for FSGS, a rare and fatal kidney disease with no

Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations

Tokyo, Japan and Cambridge, UK, 1 May 2025 – Nxera Pharma Co., Ltd. ("Nxera" or "the Company"; TSE 4565) today announces the appointment of Shinya Tsuzuki, as Head of Investor Relations. Mr. Tsuzuki will lead Nxera's